ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 196

Immunology and Immunopharmacology at Point of Care: A Quality Improvement Teaching Initiative for Rheumatology Fellows

Nina Kello1 and Anne Davidson2, 1Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine, Manhasset, NY, 2Feinstein Institute for Medical Research, Manhasset, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Education, educational innovation, immunology, pharmacotherapy and quality improvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Education Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Immunology knowledge in the rheumatology community is important for a better understanding of disease pathogenesis and management, especially in an era of an expanding number of biologic therapies. Focus on immunology and immunopharmacology within rheumatology fellowship training programs varies depending on institution, as well as the involvement and availability of immunologists. The ACGME Program Requirements for Rheumatology requires “knowledge in pharmacokinetics, metabolism, adverse events, interactions, and relative costs of drug therapies used in the management of rheumatic diseases” and 5% of the rheumatology certification exam tests immunology and pharmacology. Immunology knowledge of rheumatology fellows and attendings has anecdotally been inadequate, though official data on immunology and immunopharmacology knowledge is lacking. We hypothesized that teaching and applying immunology in the clinic setting at “point of care” would promote a better understanding of immunopharmacology.

Methods:

Over the course of 6 months, with the use of diagrams and flash cards, a brief (25min) tutorial covering the basic science behind a drug, followed by the pharmacology of said drug, was held at every fellow’s clinic by our immunologist and a senior fellow. Baseline immunology and immunopharmacology knowledge of the rheumatology fellows was determined with a pre-assessment test on the selected topic prior to each tutorial. The handouts were compiled into a book, which was available both in print and online and used on a regular basis when discussing patient management in clinic. The attending would initially model how to teach the material in a 3-5 minute format, and thereafter the fellow would use the same material to teach medical residents and students. A post-test assessment was performed 6 months after the lectures.

Results:

Rheumatology fellows showed a significant improvement in test scores after our immunology tutorials, with pre-test scores ranging from 51-68% to post-test scores 82-95%. Post-test assessments not only evaluated improvement in knowledge, but also identified areas of weakness for repeat teaching.

Conclusion:

Teaching immunology and immunopharmacology at “point of care” has proven to be an effective and well-liked tool to use in clinical practice among rheumatology fellows. Our innovative approach makes immunology clinically relevant and will indirectly improve patient care given better understanding of drug side effects and interactions. Our approach is interactive, convenient, time-efficient, flexible, easily updated, promotes the “fellow as teacher”, and can be used in the clinic even by programs with limited immunology expertise. We encourage application of this approach to future generations of rheumatology fellows within our fellowship program and beyond.


Disclosure: N. Kello, None; A. Davidson, None.

To cite this abstract in AMA style:

Kello N, Davidson A. Immunology and Immunopharmacology at Point of Care: A Quality Improvement Teaching Initiative for Rheumatology Fellows [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/immunology-and-immunopharmacology-at-point-of-care-a-quality-improvement-teaching-initiative-for-rheumatology-fellows/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immunology-and-immunopharmacology-at-point-of-care-a-quality-improvement-teaching-initiative-for-rheumatology-fellows/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology